These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30027849)

  • 21. Molecular mechanisms of pulmonary hypertension.
    Yildiz P
    Clin Chim Acta; 2009 May; 403(1-2):9-16. PubMed ID: 19361468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential expression of microRNA in the lungs of rats with pulmonary arterial hypertension.
    Xiao T; Xie L; Huang M; Shen J
    Mol Med Rep; 2017 Feb; 15(2):591-596. PubMed ID: 28000863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The emergence of new therapeutic targets in pulmonary arterial hypertension: from now to the near future.
    Malenfant S; Margaillan G; Loehr JE; Bonnet S; Provencher S
    Expert Rev Respir Med; 2013 Feb; 7(1):43-55. PubMed ID: 23362814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted therapies in pulmonary arterial hypertension.
    Montani D; Chaumais MC; Guignabert C; Günther S; Girerd B; Jaïs X; Algalarrondo V; Price LC; Savale L; Sitbon O; Simonneau G; Humbert M
    Pharmacol Ther; 2014 Feb; 141(2):172-91. PubMed ID: 24134901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The mechanistic basis of prostacyclin and its stable analogues in pulmonary arterial hypertension: Role of membrane versus nuclear receptors.
    Clapp LH; Gurung R
    Prostaglandins Other Lipid Mediat; 2015 Jul; 120():56-71. PubMed ID: 25917921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Noncoding RNAs in DNA Damage Response: Opportunities for Cancer Therapeutics.
    Arjumand W; Asiaf A; Ahmad ST
    Methods Mol Biol; 2018; 1699():3-21. PubMed ID: 29086365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondrial noncoding RNA-regulatory network in cardiovascular disease.
    Jusic A; Devaux Y;
    Basic Res Cardiol; 2020 Mar; 115(3):23. PubMed ID: 32140778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comprehensive review of web-based non-coding RNA resources for cancer research.
    Zheng Y; Liu L; Shukla GC
    Cancer Lett; 2017 Oct; 407():1-8. PubMed ID: 28823961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bromodomain-Containing Protein 4: The Epigenetic Origin of Pulmonary Arterial Hypertension.
    Meloche J; Potus F; Vaillancourt M; Bourgeois A; Johnson I; Deschamps L; Chabot S; Ruffenach G; Henry S; Breuils-Bonnet S; Tremblay È; Nadeau V; Lambert C; Paradis R; Provencher S; Bonnet S
    Circ Res; 2015 Aug; 117(6):525-35. PubMed ID: 26224795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The emerging role of non-coding RNA in essential hypertension and blood pressure regulation.
    Marques FZ; Booth SA; Charchar FJ
    J Hum Hypertens; 2015 Aug; 29(8):459-67. PubMed ID: 25391760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional Interaction between Melatonin Signaling and Noncoding RNAs.
    Su SC; Reiter RJ; Hsiao HY; Chung WH; Yang SF
    Trends Endocrinol Metab; 2018 Jun; 29(6):435-445. PubMed ID: 29631868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel molecular insights and public omics data in pulmonary hypertension.
    Lopez-Crisosto C; Arias-Carrasco R; Sepulveda P; Garrido-Olivares L; Maracaja-Coutinho V; Verdejo HE; Castro PF; Lavandero S
    Biochim Biophys Acta Mol Basis Dis; 2021 Oct; 1867(10):166200. PubMed ID: 34144090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-coding RNAs in cardiac fibrosis: Emerging biomarkers and therapeutic targets.
    Chen Z; Li C; Lin K; Cai H; Ruan W; Han J; Rao L
    Cardiol J; 2018; 25(6):732-741. PubMed ID: 29240957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role for DNA damage signaling in pulmonary arterial hypertension.
    Meloche J; Pflieger A; Vaillancourt M; Paulin R; Potus F; Zervopoulos S; Graydon C; Courboulin A; Breuils-Bonnet S; Tremblay E; Couture C; Michelakis ED; Provencher S; Bonnet S
    Circulation; 2014 Feb; 129(7):786-97. PubMed ID: 24270264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Noncoding RNAs in the development, diagnosis, and prognosis of colorectal cancer.
    Weng M; Wu D; Yang C; Peng H; Wang G; Wang T; Li X
    Transl Res; 2017 Mar; 181():108-120. PubMed ID: 27810413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BMP type II receptor as a therapeutic target in pulmonary arterial hypertension.
    Orriols M; Gomez-Puerto MC; Ten Dijke P
    Cell Mol Life Sci; 2017 Aug; 74(16):2979-2995. PubMed ID: 28447104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of new noncoding RNAs in Listeria monocytogenes and prediction of mRNA targets.
    Mandin P; Repoila F; Vergassola M; Geissmann T; Cossart P
    Nucleic Acids Res; 2007; 35(3):962-74. PubMed ID: 17259222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in gene expression profiles in patients with pulmonary arterial hypertension associated with scleroderma treated with tadalafil.
    Cheong FY; Gower AC; Farber HW
    Semin Arthritis Rheum; 2017 Feb; 46(4):465-472. PubMed ID: 27499522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emerging Role of MicroRNAs and Long Noncoding RNAs in Healthy and Diseased Lung.
    Xiao JH; Hao QY; Wang K; Paul J; Wang YX
    Adv Exp Med Biol; 2017; 967():343-359. PubMed ID: 29047098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current and future therapeutic targets for pulmonary arterial hypertension.
    Fraidenburg D; Yuan J
    High Alt Med Biol; 2013 Jun; 14(2):134-43. PubMed ID: 23795733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.